Literature DB >> 17346162

The search for a topical dual action spermicide/microbicide.

Louise M Hughes1, Renate Griffith, R J Aitken.   

Abstract

There is an urgent clinical need to research novel methods of fertility control that are also protective against sexually transmitted diseases (STDs) such as the human immunodeficiency virus (HIV) or Chlamydia. The most obvious way to generate such a dual-purpose contraceptive method would be to develop safe, effective spermicides that were also active against a wide range of pathogenic organisms. The currently available formulations such as nonoxynol-9, gramicidin and benzalkonium chloride are effective spermicides but are toxic to the vaginal epithelium and do not provide protection against STDs. Over 60 agents are in clinical trials as potentially safer topical spermicides and/or microbicides. Compounds that have reached this stage of development include acid buffers, detergents, dendrimers, non-nucleoside reverse transcriptase inhibitors and anionic polymers. In addition, a number of potential spermicides/microbicides are the subject of preclinical investigation, including beta-cyclodextrin, cyanovirin, porphyrins, cyclotriazadisulfonamides, dermaseptins, short-interfering RNA (siRNA) and HIV antibodies. The chemical principles underlying these disparate approaches and potential avenues for future investigation are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346162     DOI: 10.2174/092986707780090972

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

Review 1.  As the world grows: contraception in the 21st century.

Authors:  R John Aitken; Mark A Baker; Gustavo F Doncel; Martin M Matzuk; Christine K Mauck; Michael J K Harper
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1.

Authors:  Mei-Yun Zhang; Andrew Rosa Borges; Roger G Ptak; Yanping Wang; Antony S Dimitrov; S Munir Alam; Lindsay Wieczorek; Peter Bouma; Timothy Fouts; Shibo Jiang; Victoria R Polonis; Barton F Haynes; Gerald V Quinnan; David C Montefiori; Dimiter S Dimitrov
Journal:  MAbs       Date:  2010-05-05       Impact factor: 5.857

Review 3.  Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies.

Authors:  Andrea Ries Thurman; Meredith R Clark; Gustavo F Doncel
Journal:  Infect Dis Obstet Gynecol       Date:  2011-08-09

4.  CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics.

Authors:  Andreas Schweizer; Peter Rusert; Livia Berlinger; Claudia R Ruprecht; Axel Mann; Stéphanie Corthésy; Stuart G Turville; Meropi Aravantinou; Marek Fischer; Melissa Robbiani; Patrick Amstutz; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2008-07-25       Impact factor: 6.823

Review 5.  Human spermatozoa: revelations on the road to conception.

Authors:  R John Aitken
Journal:  F1000Prime Rep       Date:  2013-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.